Extension of Time to File SOU

PTO Form 1581 (Rev 9/2005)

OMB No. 0651-0054 (Exp. 09/30/2011)

---

PTO Form 1581 (Rev 9/2005)

OMB No. 0651-0054 (Exp. 09/30/2011)

SOU Extension Request
(15 U.S.C. Section 1051(d))

To the Commissioner for Trademarks:

MARK: MYTRADOR
SERIAL NUMBER: 77106906

The applicant, Tibotec Pharmaceuticals Ltd., having an address of Eastgate, Eastgate Village, County Cork, Ireland , requests a six-month extension of time to file the Statement of Use under 37 C.F.R. Section 2.89 in this application.    The Notice of Allowance mailing date was 05/13/2008.

For International Class 005:
Current identification: human pharmaceuticals for the treatment of auto-immune, immunological, inflammation and inflammatory diseases and disorders, cardiovascular diseases and disorders, metabolic diseases and disorders, central nervous system diseases and disorders, infectious-related diseases and disorders, anti-viral diseases and disorders, oncological related diseases and disorders, neurological related diseases and disorders, pain, dermatological related diseases and disorders, reproductive and urological diseases and disorders, and psychiatric related diseases and disorders

This filing does NOTcover the following goods or services listed in either the application or Notice of Allowance or as subsequently modified for this specific class; these goods or services are either being permanently deleted or included in a separately filed Request to Divide: auto-immune, immunological, inflammation and inflammatory diseases and disorders, cardiovascular diseases and disorders, metabolic diseases and disorders, central nervous system diseases and disorders, oncological related diseases and disorders, neurological related diseases and disorders, pain, dermatological related diseases and disorders, reproductive and urological diseases and disorders, and psychiatric related diseases and disorders

The applicant has a continued bona fide intention to use or use through the applicant's related company or licensee the mark in commerce on or in connection with the following goods or services listed in the Notice of Allowance or as subsequently modified for this specific class: human pharmaceuticals for the treatment of infectious-related diseases and disorders, anti-viral diseases and disorders

This is the first extension request.


A fee payment in the amount of $150 will be submitted with the form, representing payment for 1 class.


Declaration

The undersigned being hereby warned that willful false statements and the like are punishable by fine or imprisonment, or both, under 18 U.S.C. Section 1001, and that such willful false statements and the like may jeopardize the validity of this document, declares that he/she is properly authorized to execute this document on behalf of the Owner; and all statements made of his/her own knowledge are true and that all statements made on information and belief are believed to be true.


Signature: /carol leland/      Date Signed: 11/12/2008
Signatory's Name: Carol Leland
Signatory's Position: Company Secretary

RAM Sale Number: 14583
RAM Accounting Date: 11/12/2008

Serial Number: 77106906
Internet Transmission Date: Wed Nov 12 12:25:33 EST 2008
TEAS Stamp: USPTO/ESU-XXX.XXX.X.XXX-2008111212253375
3400-77106906-400eda0be85805c734a69f9943
9bc11ae5f-DA-14583-20081107091956715378